Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out
NEW YORK CITY, NY / ACCESSWIRE / January 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating the merger between ...
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Enfusion, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / January 20, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid
Morgan Stanley downgraded Enfusion Inc (NYSE:ENFN) stock to "Equal-weight" from "Overweight" following Clearwater Analytics' proposed $1.5 billion acquisition at $11.25 per share.With the bid ...
Hosted on MSN6d
William Blair Downgrades Enfusion (ENFN)
Fintel reports that on January 13, 2025, William Blair downgraded their outlook for Enfusion (NYSE:ENFN) from Outperform to ...
Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
NYSE:ENFN) Enfusion, Inc. Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm ...
Enfusion (NYSE:ENFN) Given “Market Perform” Rating at William Blair
Enfusion (NYSE:ENFN – Get Free Report)‘s stock had its “market perform” rating reaffirmed by equities research analysts at ...
IBS5d
Clearwater to acquire Enfusion to expand its Investment Management Platform
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news ...
Enfusion downgraded to Hold from Buy at Stifel
Stifel analyst J. Parker Lane downgraded Enfusion (ENFN) to Hold from Buy with a price target of $11.25, down from $13, after the company announced an agreement to be acquired by Clearwater Analytics ...
bovnews6d
Why Enfusion Inc (ENFN) Stock is Currently 3.50% Above from Its 20-Day SMA?
Morgan Stanley has recently resumed Enfusion Inc (ENFN) stock to Overweight rating, as announced on May 10, 2024, according to Finviz. Earlier, on February 28, 2024, Goldman had reduced the stock from ...
AFP2d
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
Clearwater Analytics (NYSE: CWAN) (“Clearwater”) and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”) today announced their entry into a definitive merger agreement for Clearwater to acquire ...
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker ...
bovnews3d
Stock Shock: The Unpredictable Rise and Fall of ENFN—What’s Driving the Drama?
Enfusion Inc (ENFN) stock saw a modest uptick, ending the day at $10.96 which represents a slight increase of $0.04 or 0.37% from the prior close of $10.92. The stock opened at $10.95 and touched a ...